Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade

PURPOSE: To analyze long-term outcomes after treatment discontinuation of anti–programmed death-1 (anti–PD-1) therapy in a cohort of patients with melanoma with the longest follow-up yet available to our knowledge, including a majority of patients treated outside of a clinical trial. We also assesse...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: Betof Warner, Allison, Palmer, Jessica S., Shoushtari, Alexander N., Goldman, Debra A., Panageas, Katherine S., Hayes, Sara A., Bajwa, Raazi, Momtaz, Parisa, Callahan, Margaret K., Wolchok, Jedd D., Postow, Michael A., Chapman, Paul B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2020
Soggetti:
Rapid Communications
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7238490/
https://ncbi.nlm.nih.gov/pubmed/32053428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01464
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi